Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | RAB9A | P51151 | 5/20 | 0.57 |
| ▸ | NPC1 | O15118 | 4/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | MITF | O75030 | 1/20 | 0.51 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3030839 | 0.85 | ALDH1A1 (0.74) | ALDH1A1KDM4ERAB9ANPC1LMNA | |
| SCHEMBL20116002 | 0.85 | ALDH1A1 (0.74) | ALDH1A1KDM4ERAB9ANPC1LMNA | |
| SCHEMBL10482619 | 0.84 | ALDH1A1 (0.72) | ALDH1A1KDM4ERAB9ANPC1LMNA | |
| SCHEMBL11380576 | 0.81 | ALDH1A1 (0.68) | ALDH1A1KDM4ERAB9ANPC1LMNA | |
| SCHEMBL4506446 | 0.81 | ALDH1A1 (0.68) | ALDH1A1KDM4ERAB9ANPC1LMNA | |
| SCHEMBL4508215 | 0.80 | ALDH1A1 (0.67) | ALDH1A1KDM4ERAB9ANPC1LMNA | |
| SCHEMBL13481990 | 0.80 | ALDH1A1 (0.66) | ALDH1A1KDM4ERAB9ANPC1LMNA | |
| SCHEMBL4518634 | 0.79 | ALDH1A1 (0.65) | ALDH1A1KDM4ERAB9ANPC1LMNA | |
| SCHEMBL30593801 | 0.79 | ALDH1A1 (0.65) | ALDH1A1KDM4ERAB9ANPC1LMNA | |
| SCHEMBL10367142 | 0.78 | ALDH1A1 (0.63) | ALDH1A1KDM4ERAB9ANPC1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115215879-B | 3-aryl-4, 5-pyranocoumarin derivative, and preparation method and application thereof | 广西中医药大学 | 2023-10-20 | — | — | CN | claimed |
| CN-115322204-B | Preparation method and application of radix glycyrrhizae glabra A and derivatives thereof | 广西中医药大学 | 2023-09-19 | — | — | CN | claimed |
| CN-115215879-B | 3-aryl-4, 5-pyranocoumarin derivative, and preparation method and application thereof | 广西中医药大学 | 2023-10-20 | — | — | CN | disclosed |
| CN-115322204-B | Preparation method and application of radix glycyrrhizae glabra A and derivatives thereof | 广西中医药大学 | 2023-09-19 | — | — | CN | disclosed |
| CN-115322204-A | Preparation method and application of glabrous greenbrier rhizome A and derivatives thereof | 广西中医药大学 | 2022-11-11 | — | — | CN | disclosed |
| EP-2254601-B1 | OLIGOMER-CANNABINOID CONJUGATES | NEKTAR THERAPEUTICS (US) | 2019-05-29 | — | — | EP | disclosed |
| US-9155797-B2 | Oligomer-cannabinoid conjugates | NEKTAR THERAPEUTICS (US) | 2015-10-13 | — | — | US | disclosed |
| US-9155797-B2 | Oligomer-cannabinoid conjugates | NEKTAR THERAPEUTICS (US) | 2015-10-13 | — | — | US | disclosed |
| US-20140329895-A1 | OLIGOMER-CANNABINOID CONJUGATES | NEKTAR THERAPEUTICS | 2014-11-06 | — | — | US | disclosed |
| US-20140329895-A1 | OLIGOMER-CANNABINOID CONJUGATES | NEKTAR THERAPEUTICS | 2014-11-06 | — | — | US | disclosed |
| US-8829043-B2 | Oligome-cannabinoid conjugates | NEKTAR THERAPEUTICS (US) | 2014-09-09 | — | — | US | disclosed |
| US-4863934-A | Bicyclic benzo fused pyran compounds used for producing analgesia | PFIZER INC. (US) | 1989-09-05 | — | — | US | disclosed |
| US-4841078-A | ANALGESICS | PFIZER INC. (US) | 1989-06-20 | — | — | US | disclosed |
| EP-0129636-B1 | PROCESS FOR THE PREPARATION OF CHROMEN DERIVATIVES | ALKALOIDA VEGYéSZETI GYáR (HU) | 1989-01-04 | — | — | EP | disclosed |
| US-4680404-A | ANALGESICS, TRANQUILIZERS, ANTIEMETICS, DIURETICS, ANTICONVULSANTS | PFIZER INC. (US) | 1987-07-14 | — | — | US | disclosed |
| EP-0129636-A1 | Process for the preparation of chromen derivatives | ALKALOIDA VEGYéSZETI GYáR (HU) | 1985-01-02 | — | — | EP | disclosed |
| US-4486428-A | ANALGESICS, ANTIEMETICS | PFIZER INC. (US) | 1984-12-04 | — | — | US | disclosed |
| EP-0089781-A2 | Bicyclic benzo fused compounds | PFIZER INC. (US) | 1983-09-28 | — | — | EP | disclosed |
| US-4243674-A | HYPOTENSIVE AGENTS; ANALGESICS; ANTISECRETORY AGENTS; ANTIBODY INHIBITORS, AND TRANQUILIZERS | PFIZER INC. (US) | 1981-01-06 | — | — | US | disclosed |
| US-4143139-A | ANALGESICS, HYPOTENSIVES, IMMUNOSUPPRESSANTS, TRANQUILIZERS, ANTISECRETORY, ANTI-ANXIETY | PFIZER INC. (US) | 1979-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140329895-A1 | OLIGOMER-CANNABINOID CONJUGATES | CNR2, CNR1, OPRL1 | ALDH1A1 3706/4885KDM4E 3026/4885RAB9A 1707/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.